StonvexLoading…
StonvexStonvexStonvexCore line items from ICLR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 |
|---|---|---|---|---|
Revenue | $8.28B | $8.12B | $7.74B | $5.48B |
Operating Income | $1.10B | $956.15M | $795.24M | $378.53M |
Net Income | $791.47M | $612.34M | $505.30M | $153.19M |
EPS (Diluted) | $9.53 | $7.40 | $6.13 | $2.25 |
Total Assets | $16.88B | $16.99B | $17.19B | $17.39B |
Total Liabilities | $7.35B | $7.75B | $8.69B | $9.32B |
Cash & Equivalents | $538.78M | $378.10M | $288.77M | $752.21M |
Free Cash Flow OCF − CapEx | $1.12B | $1.02B | $421.15M | $735.39M |
Shares Outstanding | 80.76M | 82.50M | 81.72M | 81.55M |